These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 19838927)
1. Curcumin synergizes with resveratrol to inhibit colon cancer. Majumdar AP; Banerjee S; Nautiyal J; Patel BB; Patel V; Du J; Yu Y; Elliott AA; Levi E; Sarkar FH Nutr Cancer; 2009; 61(4):544-53. PubMed ID: 19838927 [TBL] [Abstract][Full Text] [Related]
2. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells. Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. Vanamala J; Reddivari L; Radhakrishnan S; Tarver C BMC Cancer; 2010 May; 10():238. PubMed ID: 20504360 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells. Reddy S; Rishi AK; Xu H; Levi E; Sarkar FH; Majumdar AP Nutr Cancer; 2006; 55(2):185-94. PubMed ID: 17044774 [TBL] [Abstract][Full Text] [Related]
5. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Watson JL; Hill R; Yaffe PB; Greenshields A; Walsh M; Lee PW; Giacomantonio CA; Hoskin DW Cancer Lett; 2010 Nov; 297(1):1-8. PubMed ID: 20472336 [TBL] [Abstract][Full Text] [Related]
6. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice. Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019 [TBL] [Abstract][Full Text] [Related]
7. C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors. Chen C; Liu Y; Chen Y; Xu J Cancer Biol Ther; 2011 Nov; 12(9):797-807. PubMed ID: 21900746 [TBL] [Abstract][Full Text] [Related]
8. Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro. Chen MB; Wu XY; Tao GQ; Liu CY; Chen J; Wang LQ; Lu PH Int J Cancer; 2012 Dec; 131(11):2487-98. PubMed ID: 22438101 [TBL] [Abstract][Full Text] [Related]
9. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Patel BB; Sengupta R; Qazi S; Vachhani H; Yu Y; Rishi AK; Majumdar AP Int J Cancer; 2008 Jan; 122(2):267-73. PubMed ID: 17918158 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53. Chan JY; Phoo MS; Clement MV; Pervaiz S; Lee SC Cancer Biol Ther; 2008 Aug; 7(8):1305-12. PubMed ID: 18497562 [TBL] [Abstract][Full Text] [Related]
11. Curcumin β-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivo. Ozawa-Umeta H; Kishimoto A; Imaizumi A; Hashimoto T; Asakura T; Kakeya H; Kanai M Cancer Sci; 2020 May; 111(5):1785-1793. PubMed ID: 32163218 [TBL] [Abstract][Full Text] [Related]
12. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Csaki C; Mobasheri A; Shakibaei M Arthritis Res Ther; 2009; 11(6):R165. PubMed ID: 19889203 [TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of resveratrol on the growth of human colon cancer ls174t cells and its subcutaneously transplanted tumor in nude mice and the mechanism of action]. Chen J; Dong XS; Guo XG Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):15-9. PubMed ID: 19538862 [TBL] [Abstract][Full Text] [Related]
14. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species. Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Kim MY; Trudel LJ; Wogan GN Anticancer Res; 2009 Oct; 29(10):3733-40. PubMed ID: 19846903 [TBL] [Abstract][Full Text] [Related]
16. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol and curcumin synergistically induces apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21(Waf1/Cip1) mediated inhibition of Hh-Gli signaling. Mohapatra P; Satapathy SR; Siddharth S; Das D; Nayak A; Kundu CN Int J Biochem Cell Biol; 2015 Sep; 66():75-84. PubMed ID: 26212257 [TBL] [Abstract][Full Text] [Related]
18. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Sreekanth CN; Bava SV; Sreekumar E; Anto RJ Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920 [TBL] [Abstract][Full Text] [Related]
19. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Liontas A; Yeger H Anticancer Res; 2004; 24(2B):987-98. PubMed ID: 15161054 [TBL] [Abstract][Full Text] [Related]
20. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB. Du J; Wang Y; Chen D; Ji G; Ma Q; Liao S; Zheng Y; Zhang J; Hou Y Cancer Lett; 2016 Dec; 383(2):145-153. PubMed ID: 27721019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]